Total Funding
56
49
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
64484
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
- Jim Collins: co-founderPast Role: Pictage, Inc., CEO
- Adam Thomas: Chief People Officer & SecretaryPast Role: Pfizer, Director, Human Resources
About the Company
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases. The company's lead programs target patients with rare genetic metabolic diseases, including phenylketonuria and secondary hyperoxaluria. Synlogic is also hard at work on synthetic biotics to address more prevalent
conditions, including inflammatory bowel disease, cancer, and other metabolic conditions.
Women Founded
Women Led
